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Background: Age is a key determinant for the development of cardiovascular disease
and higher age coincides with an increased prevalence of obesity and physical inactivity.
The study examines the influence of physical activity on aging processes of physiological
systems focusing on the mechanisms of vascular aging.
Methods/Design: The study consists of two parts. The cross-sectional approach aims
at examining the association of physical fitness and cardiovascular risk with large and
small artery function in healthy older active (HOA, n = 40) and sedentary (HOS, n =
40) persons as well as older sedentary individuals with increased cardiovascular risk
(OSR, n = 80) aged 50–80 years. In the interventional approach, the OSR group is
randomized into a 12-week walking-based high intensity interval training (HIIT) group
or a control condition, aiming at examining the effects of HIIT on arterial function in
diseased older adults. Active lifestyle is defined as >9 metabolic equivalent of task (MET)
per week and sedentary as ≤3 MET/week. Inclusion criteria for OSR are overweight or
obesity (body mass index ≥30 kg/m2) plus at least one additional cardiovascular risk
factor. The primary outcome is arterial stiffness as determined by aortic pulse wave
velocity (PWV). The secondary outcomes are retinal arterial and venous diameters.
Further cardiovascular assessments include peripheral PWV, central haemodynamics,
retinal endothelial function, carotid intima media thickness, cardiac strain and diastolic
function as well as autonomic function and inflammation. Physical fitness is measured
by a treadmill-based spiroergometry to determine peak oxygen uptake.
Discussion: The aim of the study is to demonstrate the importance of and need for
specific physical activity programs for seniors to achieve healthier aging as a long-
term goal. Vascular function defines disease- and age-related end organ damage
and represents the potential to contain health at older age. This research will identify
cardiovascular biomarkers that best resemble underlying cardiovascular risk in age and
disease. The integrated approach will help define new recommendations for treatment
guidance of exercise therapy in an aging population.
ClinicalTrials. gov: NCT02796976; registered 02 June 2016 (retrospectively registered).
Keywords: aging, vascular function, exercise, arterial stiffness, retinal vessels
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BACKGROUND
Atherosclerotic cardiovascular disease (CVD) is a chronic
inflammatory disease of the circulatory system and it is a main
health care threat in western countries. Almost every third death
can be attributed to CVD, amounting to a total of 17.5 million
associated deaths worldwide (World Health Organization, 2014).
About 80% of CVD deaths are thought to be associated with
arterial disorders (Thom et al., 2006). Age is one of the major risk
factors for the development of CVD and demographic change
further aggravates the enormous socio-economic health care
challenge. The number of persons aged 60 or older will double
until the year 2050, which will further aggravate the burden of
age-related diseases such as CVD (World Population Prospects,
2015). Aging is associated with complex structural and functional
alterations of the vascular bed (Ferrari et al., 2003).
The rise of the obesity epidemic in the last decades is another
main underlying reason for the high prevalence of CVD. To date,
almost 70% of adults are classified as either overweight or obese as
compared to 40% 40 years ago (Lavie et al., 2009). The prevalence
of obesity and the metabolic syndrome increases with older age
(Ford et al., 2004). Physical inactivity is amain risk factor not only
for the development of obesity but also for non-communicable
diseases in general and CVD specifically. The World Health
Organization (WHO) has stated that more than three-quarters
of all CVD mortality may be prevented by appropriate changes
in lifestyle. Blair et al. found that individuals who improved from
unfit to fit over a mean follow-up of 5 years showed a reduction
in mortality risk of 44% compared to those who remained unfit
(Blair et al., 1995). In a large prospective cohort, Wen et al.
reported a 14% reduction of all-cause mortality in individuals
exercising for 90min per week or 15min per day compared to
an inactive group (Wen et al., 2011). Vigorous-intensity exercise
(>8.5 MET) seemed to yield greater health benefits in terms of
all-cause mortality reduction than moderate-intensity exercise
(4–6 MET).
High intensity interval training (HIIT) has been suggested
to be an effective training modality for secondary prevention of
CVD in older adults and seems to be superior to well-established
moderate continuous exercise training with respect to improving
not only cardio respiratory fitness but also the cardiovascular
risk profile (Helgerud et al., 2007; Wisloff et al., 2007; Tjonna
et al., 2008; Guimarães et al., 2010; Kessler et al., 2012; Molmen
et al., 2012). The risk of CVD events is considered to be
equally low for both HIIT and moderate continuous training
(MCT) intervention strategies (Rognmo et al., 2012). Exercise
training and regular PA are able to reduce the main underlying
mechanisms for the development and progression of CVD such
Abbreviations: HOA, healthy older Active; HOS, healthy older sedentary; OSR,
older sedentary at risk; HIIT, high intensity interval training; PA, physical activity;
VO2max, maximal oxygen uptake as a measure of physical fitness; MET, metabolic
equivalent; CVD, cardiovascular disease; PWV, pulse wave velocity; cfPWV,
carotis-femoral PWV; ftPWV, femoral tibial PWV; AIx, augmentation index;
AIx@75, AIx at heart rate 75/min; cPP, central pulse pressure; IMT, intima media
thickness; HRV, heart rate variability; SVA, static retinal vessel analysis; DVA,
dynamic retinal vessel analysis; CRAE, central retinal equivalent; CRVE, central
retinal equivalent; AVR, arteriolar-to-venular diameter ratio.
as inflammation, oxidative stress and endothelial dysfunction.
However, it is still unclear which biomarker is most suitable to
detect the process of vascular aging and can sensitively quantify
and monitor treatment effects at older age. Novel approaches for
cardiovascular risk screening and exercise treatment strategies
are indispensable to counteract the growing socio-economic
burden and health hazard of cardiovascular disease in an aging
population.
CARDIOVASCULAR HEALTH AND AGING:
A SYSTEMS PHYSIOLOGY APPROACH
Vascular aging is a gradual process of the circulation that is
aggravated by the development of cardiovascular risk factors
and affects both the macro- and microcirculation (Nichols
et al., 2011). Since aging is the main denominator for chronic
CVD manifestations, the concept of vascular aging has been
proposed to improve clinical guidance of patients with increased
cardiovascular risk (Nilsson et al., 2009, 2013). The concept
implies that age-related clinical or subclinical manifestations are
associated with vascular alterations, which can be quantified by
sensitive non-invasive vascular assessments. Consistent evidence
suggests that arterial stiffness is a subclinical, strong and valid
vascular biomarker for the quantification of atherosclerosis and
grave cardiovascular dysfunction (Salomaa et al., 1995; Laurent
et al., 2006; Vlachopoulos et al., 2010a). Arterial stiffness and
the impairment of the buffer capacity of large arteries lead to
elevated left ventricular afterload and left ventricular hypertrophy
and, at later stages, to heart failure, worsening of coronary
artery disease and increased risk of stroke (Hamilton et al.,
2007). Aortic pulse wave velocity (PWV), acknowledged as
the “gold-standard” method for measuring arterial stiffness,
is an independent predictor for cardiovascular morbidity and
mortality in the general population, elderly subjects and in
patients with cardiovascular disease (Laurent et al., 2001; Sutton-
Tyrrell et al., 2005; Hansen et al., 2006; Mattace-Raso et al.,
2006). An increase of aortic PWV by 1 m/s has been reported
to represent a risk increase of 15% in total cardiovascular
and all-cause mortality (Vlachopoulos et al., 2010a). In the
Baltimore Longitudinal Study of Aging, aortic PWV increased
twofold across the age span and higher fitness were associated
with reduced arterial stiffness in a predominantly sedentary
population as well as in endurance trained older men compared
to less active peers (Vaitkevicius et al., 1993). In a population-
based study of 373 younger subjects in the Netherlands, it
was found that the effect of habitual PA on arterial stiffness
depends on its intensity and differs depending on the arterial
tree segment. Vigorous but not light-to-moderate habitual PA
provides favorable associations with peripheral arterial stiffness
in young adults (van de Laar et al., 2011). In our study, different
approaches of measuring arterial stiffness are applied in various
vascular beds. Central and peripheral PWV measurements are
performed as well as 24-h monitoring of central haemodynamics
such as augmentation index (AIx) and pulse pressure (PP).
Assessment of the macrocirculation includes the structural
analysis of the carotid intima-media thickness (IMT).
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It is generally assumed that increased central PWV
contributes to the pathogenesis of small vessel disease,
particularly the myocardial and cerebral microcirculation.
Increased arterial stiffness seems to expose small vessels to
highly pulsatile pressure and flow, thereby inducing damage
to the microvascular bed (O’Rourke and Safar, 2005). A
cross-talk between large and small arteries exists, promoting
a vicious circle of increases in peripheral vascular resistance,
blood pressure and arterial stiffness, eventually leading to
the manifestation of micro- and macrovascular target organ
damage (Laurent et al., 2009). Retinal vessel analysis is a non-
invasive technique that allows the examination of the retinal
microcirculation (Liew et al., 2008). Retinal vessels are part of
the cerebrovascular bed and they are affected early in the process
of cardiovascular disease. Large cohort studies have previously
shown that narrower retinal arterioles, wider retinal venules
and a resulting lower arteriolar-to-venular diameter ratio (AVR)
are associated with increased risk and severity of hypertension
(Wang et al., 2003; Wong et al., 2004a; Ikram et al., 2006b),
risk of stroke (Ikram et al., 2006a; McGeechan et al., 2009)
and a higher cardiovascular morbidity and mortality in older
subjects (Wong et al., 2002; Wang et al., 2007). In older adults,
obesity is associated with retinal venular widening and a lower
arteriolar-to-venular diameter ratio (AVR) (Nguyen and Wong,
2006; Wang et al., 2006). Inflammation has been associated with
wider retinal venular diameters (Klein et al., 2006). We have
previously shown that higher physical fitness levels are associated
with higher retinal AVR and that regular endurance exercise
induced arteriolar dilatation as well as venular constriction,
leading to a significantly improved AVR in middle-aged lean and
obese individuals (Hanssen et al., 2011). Retinal microvascular
endothelial function can directly be measured in vivo by dynamic
retinal vessel imaging inducing neurovascular coupling by flicker
stimulus (Falsini et al., 2002; Polak et al., 2002). An impaired
response to flicker light has been associated with type 2 diabetes
mellitus (Mandecka et al., 2007; Sörensen et al., 2016), high
blood pressure (Nagel et al., 2004) and aging (Pemp et al., 2009;
Kotliar et al., 2011). The assessment of retinal vessel diameters is
used to define microvascular aging at older age and to examine
associations with physical fitness. Retinal vessel analysis allows
for the investigation of the cross-talk between large and small
arteries.
Large artery stiffness is not only associated with small vessel
disease but is known to relate to left ventricular hypertrophy
as well as systolic and diastolic dysfunction (Roman et al.,
2000; Weber et al., 2008; Namba et al., 2016). In patients
with normal ejection fraction, increased pulse wave reflection
and PWV are associated with higher left ventricular filling
pressures (Weber et al., 2008). In patients with asymptomatic
diastolic dysfunction, increased PWV has been shown to precede
the onset of manifest heart failure with preserved ejection
fraction (Karagodin et al., 2017). Indices of systolic and diastolic
function share its predictive character with arterial stiffening
(Vlachopoulos et al., 2010b; Kane et al., 2011; Lam et al., 2011).
This suggests that ventricular-vascular interactions play a pivotal
role in the clinical relevance of arterial stiffness (Chung et al.,
2010). The recent Health ABC Study, however, demonstrated that
the association of arterial stiffness with the development of heart
failure is not independent of cardiovascular risk factors (Pandey
et al., 2017). Additional assessment of left ventricular structure
and function allows for analysis of the cardiovascular cross-talk
and its association with cardiovascular risk factors.
Autonomic function (AF) is a principal regulator of vascular
properties and cardiac function. AF alters with age and plays
a crucial role in the development of cardiovascular diseases
(1996; Fisher et al., 2009). Its sympathetic and parasympathetic
branches regulate vascular tone and, thereby, modulate arterial
stiffness (Perkins et al., 2006). Heart Rate Variability (HRV) is
an easily recordable clinical marker for autonomic function and
its indices have shown predictive value for the development
of cardiovascular disease (1996; Kleiger et al., 2005). Increased
physical activity has been shown to be associated with favorable
autonomic function in older adults (Soares-Miranda et al.,
2014). In addition to the above mentioned physiological systems,
we will measure circulating anti- as well as pro-inflammatory
cytokines and analyse their role in mediating physical inactivity-
and obesity-related vascular and systemic impairments. Vascular
aging and immunosenescence are explained in large part by
an imbalance between inflammatory and anti-inflammatory
processes. These result in a predominantly pro-inflammatory
status that has been termed “inflamm aging” (Franceschi et al.,
2007). Healthy aging and longevity are the result of an efficient
lifelong anti-inflammatory activity that, once it fails to overcome
cellular and systemic inflammatory processes, can be the driving
force for frailty and age-related pathologies.
METHODS/DESIGN
Objectives
The aims of the study are twofold. In our cross-sectional research
approach, the association of physical activity and fitness on the
process of normal (healthy) aging is analyzed by comparing the
group of healthy older sedentary (HOS) with healthy older active
(HOA) adults. The association of CVD on the process of aging
is examined by comparing HOS with older sedentary persons
with increased cardiovascular risk (OSR). In the interventional
approach, the reversibility of advanced vascular and systemic
aging by a walking-based HIIT is examined in OSR.
Cross-Sectional (Part I)
Aim 1: To determine the associations of physical fitness and
cardiovascular disease with large and small artery function in
HOA, HOS as well as OSR group.
Interventional (Part II)
Aim 2: To examine the effects of HIIT on large and small artery
function in OSR.
Outcome Measures
Primary outcome: central (carotid-femoral) pulse wave velocity
(cfPWV)
Secondary outcomes: central retinal arteriolar (CRAE) and
venular (CRVE) diameters
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Further outcomes: peripheral (femoral-posterior tibial) pulse
wave velocity (ftPWV); central augmentation index (cAIx);
central pulse pressure (cPP); 24 h AIx (24AIx) and cPP
(24cPP); carotid intima media thickness (IMT); retinal vessel
flicker response (DVA); left ventricular diastolic function and
myocardial strain; heart rate variability (HRV), inflammation.
Hypotheses
Hypothesis 1 (Part I): cfPWV is lower in HOA compared to HOS
Hypothesis 2 (Part I): cfPWV is higher in OSR compared to HOS
Hypothesis 3 (Part II): cfPWV inOSR can be reduced by 12 weeks
of HIIT compared to controls.
The same hypotheses will be addressed for the secondary and
further outcomes.
Study Design
The study design consists of two parts with separate sample
size considerations for the cross-sectional and interventional
approach. HOA and HOS participants as well as OSR are
recruited and enrolled in the cross-sectional study (Figure 1).
Recruitment of the OSR group is performed on the basis of
agreement to take part in the exercise intervention following
the cross-sectional assessment, which serves as a baseline
examination for the consecutive intervention. Before enrolment,
subjects are medically examined and scanned for inclusion and
exclusion criteria by the study physician. Written informed
consent is obtained from eligible subjects and a medical
examination and anthropometry are performed and physical
activity levels are assessed. In addition, blood sampling and 24 h
blood pressure monitoring including central PWV, Aix, and PP
are undertaken (visit 1). The enrolment decision is taken on the
basis of the inclusion and exclusion criteria. On two separate
visits and in randomized order, the main vascular diagnostics,
echocardiography, autonomic function and the assessment of
endurance performance (VO2max) are performed for the cross-
sectional part of the study. All vascular diagnostics take place
in the morning and under fasting conditions (visit 2 or 3). The
endurance performance and the autonomic function is always
performed in the afternoon (visit 2 or 3) to reduce within-
day variability. Visit 1 and visit 2/3 are separated by at least
1 week to check inclusion/exclusion criteria. Visit 2 and 3 are
separated by at least 1 day or no more than 2 weeks. After
these three visits, the OSR group is randomized to take part
in a 12-week HIIT or a control condition with general lifestyle
recommendations. All participants have an equal likelihood of
being assigned to treatment or control group. All assessments of
the baseline examination are repeated in the follow-up after 12
weeks (Figure 1).
Inclusion Criteria
• Healthy men and women aged 50–80 years with:
- active lifestyle: >9 MET/week (>3 h moderate
walking/week) or
- sedentary lifestyle: ≤3 MET/week (≤1 h moderate
walking/week)
- 18.5≤ BMI < 25.0 kg/m2
• Sedentary men and women aged 50–80 years with increased
cardiovascular risk:
- overweight or obesity (BMI ≥ 30 kg/m2) and
- ≥one additional cardiovascular risk factor as described in
Figure 2.
Exclusion Criteria
• Healthy men and women aged 50–80 years with:
History of cardiovascular, pulmonary or chronic
inflammatory disease; blood pressure ≥140/90 mmHg during
24 h monitoring or any of the risk factors in Figure 2; current or
past smoker; macular degeneration or glaucoma.
• Sedentary men and women aged 50–80 years at risk:
Decompensated cardiovascular, pulmonary or chronic
inflammatory disease; macular degeneration or glaucoma;
compromising orthopedic problems.
Setting
The RCTwill be realized at the Department of Sport, Exercise and
Health, Basel, Switzerland. This study is financially supported by
the Swiss National Science Foundation (SNF) and approved by
the Ethics Committee of Northwestern and Central Switzerland
(EKNZ-2015-351). We registered this study on ClinicalTrials.gov
(NCT02796976) in June 2016.
Study Procedures and Ethical
Considerations
All participants are briefed verbally and receive information
approved by the Ethics Committee of Northwestern and Central
Switzerland (EKNZ) giving details on the study procedures,
the RCT and the process of randomization. The study will be
carried out in accordance to the protocol and with the principles
stated in the Declaration of Helsinki and the Guidelines of
Good Clinical Practice (GCP) (World Medical Association,
2013). This study protocol was design according the SPIRIT
Guidelines.
All measurements and procedures applied in this study are
non-invasive. Routine exercise ECG includes an exertional
stress test as a medical necessity and safety precaution to
evaluate cardiorespiratory health in all subjects. The OSR
group undergoes a high intensity walking-based training
program. HIIT has previously been applied in a wide range
of patients including patients with coronary artery disease.
The risk for cardiovascular events has been proven to
be equally low for both HIIT and moderate continuous
intervention strategies (Rognmo et al., 2012). Retinal vessel
analysis includes mydriasis of one eye. Using a mydriaticum
(Tropicamid 0.5%), the pupils are dilated and enable
retinal vessel analysis. The eye drops can cause temporary
discomfort, oftentimes a burning sensation for 1–2min.
Flickerlight exposure can potentially cause slight headaches.
The collaborating ophthalmology department in Basel will
offer back up at all times in the unlikely event of continuous
discomfort.
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FIGURE 1 | Study design, cross-sectional part (Part I) and randomized controlled trail (RCT) (Part II); HOA, healthy older active; HOS, healthy older sedentary; OSR,
older sedentary at risk; CG, control group (standard recommendations for daily physical activity); HIIT, high intensity interval training.
All participants are committed to sign a consent form and
will be informed about their right to withdraw from the study
without any consequences. A study assistant will randomize the
OSR group in an intervention or a control group by drawing
a lot after the last pre-intervention assessment. Participants
and investigators are blinded for the group membership during
the pre-measurements. All participants are to be recruited
from our outpatient department, the Metabolism Unit of the
University Hospital Basel, Basel, Switzerland and, in addition,
with postings on University webpages and advertisements
in local newspapers. We aim to recruit the HOA group
in running clubs and on running events in and around
Basel. A total of 160 participants will be recruited for the
study.
Statistical Analysis
The primary outcome of the study is the cfPWV among HOA,
HOS, and OSR (part I), and among OSR after 12 weeks of
intervention with a high-intensity interval training (HIIT) and
those assessed within the same time frame without the HIIT
intervention (control group) (part II). To describe continuous
demographic and baseline characteristics of participants in the
HOA, HOS and OSR group (part I) and those in the OSR
intervention and control group (part II), we will use the median
and interquartile range; and for categorical characteristics, we
will use percentages. Boxplots will be used to visualize the
primary and secondary outcomes in the HOA, HOS and OSR
group (part I) and at baseline as well as after 12 weeks in
the OSR intervention and control group (part II). For part
I, we will use analysis of variance to compare the cfPWV
(and secondary outcomes) between HOA, HOS and OSR. For
part II, we will use analysis of covariance to compare the
cfPWV (and secondary outcomes) after 12 weeks between OSR
in the intervention and those in the control group adjusted
for the corresponding values at baseline (Vickers and Altman,
2001). For each analysis, we will report estimates (with 95%
confidence intervals) of the difference in outcome between
HOA and HOS and between OSR and HOS (part I), and
between OSR in the intervention and those in the control
group (part II). Up-to-date versions of SAS (SAS Institute
Inc., Cary, NC, USA) and R (R Foundation for Statistical
Computing, Vienna, Austria) will be used for analysis and
graphics.
Sample Size Calculation
The sample size was calculated separately for both study parts.
For part I, we assumed that the expected cfPWV corresponded
to 8.5, 9.5, and 11.5 m/s for HOA, HOS and OSR, respectively,
and that the standard deviation was 1.5 m/s (Tedesco et al.,
2004; Gando et al., 2010). With a 2-sided significance level
of 0.05, the sample size needed to attain a targeted power of
80% for detecting a difference with magnitude 1.0 m/s was 36
participants per group (the comparison between HOA and HOS)
and for detecting a difference with magnitude 2.0 m/s, it was
10 participants per group (the comparison between OSR and
HOS). For part II, we assumed that the expected difference in
cfPWV after 12 weeks between OSR in the intervention and
those in the control group was 1.0 m/s and that the standard
deviation was 1.5 m/s (Madden et al., 2009). By including the
baseline cfPWV (before the start of the intervention period) as
a covariate in the pre-specified analysis, we will further reduce
error variability and therefore assumed that the correlation
between baseline and outcome cfPWV was 0.3. With a 2-
sided significance level of 0.05, the sample needed to attain a
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FIGURE 2 | Inclusion criteria and risk factors for older sedentary at risk group (OSR).
targeted power of 80% for showing superiority of the intervention
over control was 34 participants per group. Taking dropouts
into account, we plan to include a total of 40 HOA, 40 HOS
and 80 OSR. The POWER and GLMPOWER procedures in
SAS 9.3 (SAS Institute Inc., Cary, NC, USA) were used for
sample size calculation for the first and second study part,
respectively.
Exercise Intervention and Control
Condition
High Intensive Interval Training (HIIT)
The exercise intervention for the OSR intervention group is a
supervised Nordic-Walking training three times a week with
gradually increased intensity during the first 2 weeks. In the
first week, we will teach Nordic Walking technique, warm-up
and cool-down elements as well as continuous walking training
with moderate intensity at 75% of maximal heart rate (HRmax).
In the second week, the intensity will increase to 80–90% of
HRmax. In the following 10 weeks, HIIT will be performed as
described below. Exercise scientists will supervise all training
sessions.
The following protocol will be used (modified from Wisloff
et al., 2007):
• Three supervised trainings per week
• Intensity: 10min warm-up at 65-70% HRmax, 4x4min
interval training at 80-90% HRmax with 3min of active
recovery at 65-70% HRmax, 10min cool down at 60-70%
HRmax
• Duration: 45 min
Control Group (CG)
The control group is asked to orientate their physical activity
according to the European Guidelines on vascular disease
prevention in clinical practice (Backer et al., 2003).
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IMAGING METHODS AND COURSE OF
MEASUREMENTS
Macrovascular Aging
Central Pulse Wave Velocity
Carotid-femoral PWV (cfPWV), the gold standard for the
measurement of arterial stiffness, is assessed by using a
SphygmoCor R© device (AtCor, Medical Pty Ltd, Sydney,
Australia). The good intra- and interobserver reproducibility of
this technique has been demonstrated in healthy populations and
in patients with chronic kidney disease (Frimodt-Møller et al.,
2006, 2008). After 10min of rest, pulse waves are recorded using
a high-fidelity tonometric transducer at two sites (right carotid
artery and right femoral artery). Pulse wave travel distance is
determined by subtracting the distance between the manubrium
to the carotid artery from the distance between the femoral
artery to the manubrium as previously described (Townsend
et al., 2015). cfPWV measurements are considered to meet the
quality control parameters if two consecutive measurements
are visually acceptable and within 1 m/s of each other with
a standard deviation of <10% (Sigrist et al., 2010). If this
criterium could not be reached a third measurement was applied.
The mean of all valid measurements represents the cfPWV
value.
Peripheral Pulse Wave Velocity
Femoral-tibial PWV (ftPWV) is assessed by using the same
SphygmoCor R© device as for central PWV. Peripheral PWV is
determined as the travel time of the pulse wave between the two
recording sites at the femoral artery and the posterior tibial artery
divided by the distance between the two recording sites. All other
procedures and conditions are the same as for central PWV (see
above).
Pulse Wave Reflection (PWA)
AIx and AIx@75 are measured using the gold standard device
for single measurements (SphygmoCor R©). The augmentation
index from the central pulse is calculated as: AIx = 100 ×
(P2 – P1)/pulse pressure, where P2 is the peak of the reflected
backward wave, P1 is the peak of the forward pressure wave
and central pulse pressure is the systolic pressure maximum
minus the diastolic pressure. A positive AIx would indicate
an augmentation of peak systolic pressure by the reflected
wave. Pulse waveform is obtained using applanation tonometry
(SphygmoCor R© device, ATCor Medical, Sydney, Australia) on
the right radial artery. Ten-second recordings are accumulated
until either two analyses with a quality index of≥90% or three of
≥80%were available. By applying a generalized transfer functions
(GTF) the central arterial pulse waveform is estimated by the
SphygmoCor R© software. These transfer functions have been
validated previously during rest (Gallagher et al., 2004) and
exercise (Sharman et al., 2006). The calculated central arterial
pulse waveform is subjected to further analysis, such as the
determination of AIx and AIx@75. Reproducibility has been
shown to be acceptable at rest (Filipovský et al., 2000) and during
exercise (Holland et al., 2008).
24-h Ambulatory Monitoring of Central
Hemodynamics
Twenty-four hours ambulatory pulse wave monitoring is
obtained using an oscillometric Mobil-O-Graph R© 24 h PWA
Monitor device (I.E.M GmbH, Germany) with integrated
ARCSolver R© software. Based on the oscillometric data, central
hemodynamics as well as the 24-h PWV is calculated.
Oscillometric pulse wave analysis are performed every 20min
for 24 h. Subjects are instructed to hold their arm as steady as
possible during the measurements but otherwise maintain their
daily routine with no additional physical activity while wearing
the device. After data readout, every individual measurement is
reviewed for erroneous values. Values are deleted if the quality of
data is graded 3 or 4 by the ARCSolver R© software. The methods
used for these analyses are the same as used by the SphygmoCor R©
software described previously (Wassertheurer et al., 2010).
Validity and reproducibility of oscillometric estimates of cPP,
Aix, and AIx@75 are comparable with laboratory settings
(Wassertheurer et al., 2010; Luzardo et al., 2012; Papaioannou
et al., 2013).
Intima Media Thickness (IMT)
For the semi-automatic evaluation of intima-media thickness
(IMT), B-Mode clips are conducted using an ultrasonic device
UF-870AG (Fukuda Denshi, Japan) according to current
guidelines (Touboul et al., 2012). With the participant in supine
position and the head rotated by 45◦ either to the left or
right side two locations on both sides are scanned. Ear-to-
ear and horizontal clips are recorded over at least three heart
cycles using the US machines inbuilt 3-lead ecg function. Post
procession and video-based IMT-admeasurement of the exported
clips is performed using the Dynamic Artery Analysis software
(DYARA) as described elsewhere (Teynor et al., 2012), using
image averaging over three heart cycles. Reproducibility of the
aforementioned method is excellent (Touboul et al., 2012).
Microvascular Aging
Static Retinal Vessel Analysis (SVA)
The retinal microcirculation is easily accessible by using the
Retinal Vessel Analyser (RVA, IMEDOS Systems, Jena, Germany)
and a fundus camera (450 FF; Carl Zeiss, Jena, Germany). The
technique allows for the analysis of the structure and function
of retinal arterioles and venules. To measure retinal vessel
diameters, we analyze three valid pictures from one eye with
an angle of 50◦ and the optic disc in the center. The detailed
procedure is described elsewhere (Hanssen et al., 2011). Briefly,
retinal arterioles and venules, coursing through an area of 0.5–1
disc-diameter from the optic disc margin, will be identified semi-
automatically at higher magnification using special analyzing
software (Vesselmap 2, Visualis, Imedos Systems UG). Diameters
will be averaged to central retinal arteriolar (CRAE) and venular
(CRVE) equivalents, and the arteriolar-to-venular-ratio (AVR)
will be calculated from the CRAE and CRVE. The inter-
observer and intra-observer interclass correlation coefficient for
the measurement of retinal vessel diameters ranges from 0.75 to
0.99 (Hubbard et al., 1999; Wong et al., 2004b).
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Dynamic Retinal Vessel Analysis (DVA)
Functional retinal vessel analysis requires pharmacological
dilatation of one pupil with conventional eye drops (Tropicamide
0.5%). Microvascular function is analyzed by a flicker-induced
dilatation of retinal arterioles and veins. We use a fundus camera
(450 FF; Carl Zeiss, Jena, Germany), with a charge-coupled device
for electronic online imaging and a personal computer for system
control, analysis and recording of the obtained data, allowing
non-invasive assessment of retinal endothelial function mediated
by neurovascular coupling following flicker stimulation (Falsini
et al., 2002; Polak et al., 2002). The whole procedure is described
elsewhere (Nagel et al., 2004; Gugleta et al., 2006; Garhofer et al.,
2010). Due to the described inter- and intra-individual variations
of vessel diameters (Hubbard et al., 1999), the mean diameter
resulting from three baseline measurements before application of
the stimulus in each of three flicker cycles is defined as 100%.
The ensuing vessel diameter changes are recalculated in % to
this individual baseline value (Pemp et al., 2009). From the
median of the three curves, parameters such as maximal vessel
dilatation, maximal reactive vessel constriction and area under
the reaction curve during and after flicker stimulation can be
analyzed (Kotliar et al., 2011).
Cardiac Aging
Echocardiographic parameters are assessed using an ultrasonic
device (UF 870AG, Fukuda Denshi, Japan) according to current
guidelines (Nagueh et al., 2009; Lang et al., 2015). Briefly,
global systolic function is described by ejection fraction based
on chamber quantifications as recommended. Linear method
and 2D based formulas are used to calculate left ventricular
functionmass. Right ventricularmeasurements (such as tricuspid
annular plane systolic excursion) as well as atrial volume
measurements give further insight into mechanical properties
of the heart. Diastolic function is assessed using mitral inflow
patterns (E, A, deceleration time, intraventricular relaxation
time), tissue Doppler derived mitral annular velocities (E′, A′)
and pulmonary artery pressures. Additionally, speckle tracking
echocardiography is used to calculate strain.
Autonomic Aging
We record a 12-lead-ECG for 20min in supine position before
and 10min after a treadmill test using Custo Diagnostic Software
(Custo Med GmbH, Germany). The additional post-treadmill
assessment will enable us to evaluate recovery of HRV after
acute bouts of exhaustive exercise. Raw data are extracted and
processed to derive HRV parameters. Time-domain parameters
are standard deviation of normal to normal (NN) RR intervals
(SDNN), root mean square of successive differences (RMSSD)
and the number of pairs of successive NNs that differ by more
than 50ms (NN50). Frequency-domain paramters include high-
and low frequency power. Additionally, Heart Rate Turbulence
(HRT) and Deceleration Capacity (DC) are calculated (Schmidt
et al., 1999; Bauer et al., 2006).
Inflamm-Aging and Circulating CV Risk Factors
To analyse the influence of physical activity on immunological
processes and the association of inflammation, blood samples
are taken. They are drawn by venepuncture of the cubital fossa
of the right or left arm by trained medical staff in a fasting
state. The blood is transported directly to the clinical chemistry
laboratory for further analysis or centrifuged and put on ice.
Clinical routine measurements including total blood count,
total cholesterol (TC), low- (LDL) and high-density lipoprotein
(HDL), triglyzerides (TGA) (colorimetric tests) as well as
fasting glucose levels (hexokinase reference method) and insulin
levels (automated immunoanalyzer system) to estimate insulin
resistance (by HOMA Score) are measured. Samples, which are
not analyzed directly, will centrifuged and the plasma aliquots
will be frozen at a temperature of −80◦. To analyse plasma
concentration of the following specific biomarkers blood samples
will be defrosted and processed. Cytokine-specific ELISA kits
will use to analyse inflammatory serum biomarker interleukin
6 (IL 6), 10 (IL-10), and tumor necrosis factor alpha (TNF-α)
according to the manufactures instructions (IL-6/-10: Bender
Med-Systems (eBioscience), Austria; TNF-α: Bio-source, USA).
The samples will be distributed in duplicates on the plates
and the intra-assay and inter-assay coefficient of variation need
to be ≤10%. High-sensitive c-reactive protein (hsCRP) will be
analyzed by immunoturbidimetric latex CRP assay (Cobas 8000,
Roche-Diagnostics, Basel).
Physical Fitness, Physical Activity, and
Anthropometry
Physical fitness will be assessed by performing an individualized
ramp protocol on the treadmill. We will measure peak oxygen
uptake (VO2peak) and maximal heart rate (HRmax). The
individualized design with increasing speed and ramp steepness
will be used to reach volitional exhaustion after approximately
10min for every participant. The calculation of this protocol
is based on the subject’s age and estimated peak metabolic
equivalent units (METS) as previously recommended (Bader
et al., 1999; Myers and Bellin, 2000). The ECG will be monitored
by medical personal during the whole test. Blood pressure will be
measured during, immediately after and 3min after the exercise
test. Every minute Ratings of Perceived Exertion (RPE) will
be requested (Borg, 1982). Ventilatory parameters, including
VO2max and heart rate, will be measured by using the Cortex
Metalyzer R© 3B metabolic test system (Cortex Biophysik GmbH,
Leipzig, Germany).
All participants will get an accelerometer (Aipermon GmbH,
Germany) to analyse their physical activity (PA). They have
to wear the device on their left hip for the whole day on six
consecutive days. Raw data will be copied onto a computer
and the data will be viewed using the ActiCoach MPAT2Viewer
(Aipermon, GmbH, Germany). The following parameters can
be analyzed by this software: total time (minutes per day)
spent passively (PAS), actively (ACT), walking (WLK), and fast
walking (FWLK). Walking and fast walking times will be joined
to a total walking time (TWT). We have previously validated
activity modes and accelerometer detection precision (Jehn et al.,
2009a,b, 2010, 2011).
Self-reported PA will be measured with the Freiburg
Questionnaire of physical activity. The questionnaire interrogates
health-related physical activities using self-reported activities
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within the last week/month. It creates reliable and valid values
of PA and inactivity (Frey et al., 1999). The total PA is expressed
in hours per week. The Ainsworth Compendium in metabolic
equivalents (METS) estimates the intensities. The formula to
calculate the energy expenditure per week is described elsewhere
(Ainsworth et al., 1993).
Anthropometric data will be measured in a fasting state in
the morning. The Inbody 720 R© (JP Global Markets GmbH,
Germany) device will be used to obtain weight, BMI, skeletal
muscle mass and body fat (Anderson et al., 2012). Height
and waist circumference will be measured by using a normal
measuring tape with respect to current guidelines.
Potential Pitfalls
Our main outcome (cfPWV) as well as most other vascular
measurements are affected by age, hemodynamic variability,
lifestyle behavior, and circadian fluctuations. To minimize
external interference and variability, several measures are
considered. Groups are matched for age and sex. Standardized
vascular imaging is performed under fasting conditions in the
morning after 10min of rest in a supine position. Participants
are encouraged to refrain from alcohol, caffeine and if applicable
from smoking 12 h prior to the examinations. Exercise and
vigorous physical activity should not be performed 24 h before
the visits. The OSR group is allowed to take their medication in
the morning. These measures help to minimize intra-individual
as well as within-day variability.
Change of medication or start of a structured diet during the
12 week-week intervention or control condition are indications
for exclusion. In addition, the start of structured exercise in the
control group is considered an exclusion criterion. To prevent
the start of exercise in the control group, all participants of
this group are invited to take part in the voluntary supervised
exercise program after the post measurements. To prevent high
drop-out rates and optimize adherence to the exercise regime,
every exercise session starts with strength, mobilization and
coordination exercises and includes a warm-up and a cool-down.
The first 2 weeks of the exercise program focus on technical and
coordinative skills at lower intensities before HIIT is started in
the third week into the program.
DISCUSSION AND CONCLUSION
The study design offers a concept for a systems physiology
approach on the mechanisms of aging and the role of physical
activity and fitness. The cross-sectional approach enables to
investigate the association of physical activity with the process
of normal, healthy aging comparing the HOA group with
HOS. In addition, the impact of cardiovascular disease on
physiological functioning is examined by comparing the HOS
group with OSR. The reversibility of pathophysiological aging
in patients with cardiovascular risk is explored by applying
an interventional exercise treatment in the OSR group. Our
study concept investigates the interplay of physiological systems
and how these are affected by physical activity and fitness. To
what extent can physical fitness prevent or delay physiological
dysfunction? The study aims at clarifying some of the main
mechanisms bywhich exercise improves the process of aging. The
multimodal concept of the study is depicted in Figure 3.
The ExAMIN AGE Study resembles new approaches in the
structural and functional diagnostics of aging processes including
systems such as the vasculature, the heart, autonomic function
and inflammation. The results have a focus on vascular imaging
and on the non-pharmaceutical treatment of vascular health
in older inactive individuals at risk. The integrative approach
will help to determine the best non-invasive means to diagnose
FIGURE 3 | Principle concept of the systems physiology approach.
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and define cardiovascular risk in advanced age and disease.
This study design allows the examination of pathophysiological
links between small and large arteries, the so called “vascular
coupling” or “arterial cross-talk.” To date little is known about
the interaction between the two vascular beds and how they affect
each other. It also enables to examine the cross-talk between the
vasculature and the heart. Exercise interventions can improve
both entities and play a key role in the treatment of cardiovascular
and metabolic diseases.
Our study has some limitations. We are aware that the
recruitment of healthy older sedentary individuals (HOS) is
challenging. It needs to be ascertained that all three groups
are strictly matched for age. The analysis of the association of
physical fitness with cardiovascular health and aging processes
in the three groups represents a cross-sectional approach and is
not based on prospective longitudinal data. Life-long activity is
analyzed by subjective reporting but is supported by objective
analysis using accelerometry and spiroergometry. The cross-
sectional study design does not give evidence of a temporal
relationship between physical activity exposure and physiological
outcome. However, the interventional part of the study, where
participants are randomly allocated to the intervention or the
control group, allows for a causal and temporal analysis of
the improvement of aging processes in individuals at risk. The
extensive phenotyping of vascular health and other physiological
systems as well as the analysis of the impact of HIIT are the main
strengths and innovations of the study.
In conclusion, the concept links cardiovascular prevention
and exercise medicine in a systems physiology approach. It aims
to help define new recommendations for treatment guidance of
exercise therapy in an aging population. We aim to demonstrate
the importance of specific physical activity programs for seniors
to achieve healthier aging as a long-term goal. Amelioration of
vascular function represents improvement of disease- and age-
related end organ damage and best describes the potential to
contain vascular health. The study will generate results which
will help to understand better the mechanisms of vascular aging
and the interplay with other physiological systems. The study
approach has the potential for transfer in other age groups and
clinical settings.
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